Skip to main content
    T

    Treace Medical Concepts Inc (TMCI)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $4.42
    -0.85 (-16.13%)

    Market Cap: $345.50M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Treace Medical Concepts Inc (TMCI) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Treace Medical Concepts (TMCI) to earn -$0.80 per share in the fiscal year ending Dec 31, 2026, on revenue of $207.87M. Of 5 analysts, 1 rates the stock Buy or Strong Buy, 3 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 5 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 3.20, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 20% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy120.0%
    Hold360.0%
    Sell00.0%
    Strong Sell120.0%
    Consensus
    Hold
    Total analysts
    5

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates rise 6.1%.

    Fiscal year ending Dec 31, 2026
    -$0.80
    EPS consensus, revenue $207.87M
    Fiscal year ending Dec 31, 2027
    -$0.85
    EPS consensus, revenue $220.59M
    Next report
    Feb 25, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.80-$0.81 to -$0.804$207.87M$207.64M to $208.02M5
    Dec 31, 2027-$0.85-$0.85 to -$0.851$220.59M$218.40M to $223.70M5

    Quarterly Estimates

    The EPS consensus falls from -$0.08 for the quarter ending Dec 31, 2026 to -$0.26 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.08-$0.11 to -$0.057$68.61M$65.56M to $71.40M7
    Mar 31, 2027-$0.26-$0.27 to -$0.263$50.80M$50.40M to $51.00M3

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 7 upward and 1 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202650
    Fiscal year ending Dec 31, 202701
    Quarter ending Mar 31, 202720

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$0.85.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$0.80-$0.85-$0.85-$0.85-$0.85N/A
    Fiscal year ending Dec 31, 2027-$0.85-$0.90-$0.90-$0.90-$0.90N/A
    Quarter ending Mar 31, 2027-$0.26-$0.25-$0.25-$0.25-$0.25N/A

    Frequently Asked Questions About TMCI

    What is the TMCI stock forecast?

    Consensus analyst estimates put Treace Medical Concepts's EPS at -$0.80 for the fiscal year ending Dec 31, 2026, on revenue of $207.87M. The consensus rating from 5 analysts is Hold.

    How do analysts rate TMCI stock?

    Of 5 analysts covering Treace Medical Concepts, 0 rate it Strong Buy, 1 Buy, 3 Hold, 0 Sell and 1 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from TMCI next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.80, with estimates from -$0.81 to -$0.80 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.85, with estimates from -$0.85 to -$0.85 from 1 analyst.

    What revenue do analysts expect from Treace Medical Concepts next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $207.87M, with estimates from $207.64M to $208.02M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $220.59M, with estimates from $218.40M to $223.70M.

    How many analysts cover TMCI?

    5 analysts rate Treace Medical Concepts stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.